Smart oxygen machine could ease breathing for COPD patients

NCT ID NCT07222410

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a device called Airvo 3, which automatically adjusts oxygen levels, can keep COPD patients' blood oxygen in a healthy range better than manual adjustments by nurses. About 70 hospitalized adults with COPD and low oxygen will take part. The goal is to see if the smart system reduces time spent with too little or too much oxygen.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Closed loop oxygen control device (Airvo 3 in OptiO2 mode)
What this could lead to
If it works, this could make oxygen therapy more precise and reduce the need for constant nurse adjustments in hospitalized COPD patients.
What could go wrong
This is a small early-stage study with only 70 participants, so results may not apply to all COPD patients. The device may not significantly improve oxygen control over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Central Iowa Hospital Corp - UnityPoint Health

    RECRUITING

    Des Moines, Iowa, 50309, United States

  • Icahn School of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029, United States

  • Temple University Hospital

    RECRUITING

    Philadelphia, Pennsylvania, 19140, United States

  • The University of Alabama at Birmingham

    RECRUITING

    Birmingham, Alabama, 35294, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.